Stock analysis, AI verdict, fundamentals & technical signals
Rating: HOLD
Price: $13.32 Analyst target: $17.60 Upside: 32.08%
Bioventus Inc., a medical device company, focuses on developing and commercializing clinical treatments that involve and enhance the body's natural healing process in the United States and internationally. The company is headquartered in Durham, North Carolina.
See the full interactive analysis & chart →Informational only — not investment advice.